Home > Insider Trading > Filing (0001209191-14-003130)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1009356	Salix Pharmaceuticals Ltd	SLXP	Pharmaceutical Preparations (2834)	943267443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212667	Thomas Alonzo D	8510 Colonnade Center Drive Raleigh NC 27615		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-01-10	22,500	$18.87	110,024	No	4	M	Direct
Common Stock	Disposition	2014-01-10	12,000	$91.83	98,024	No	4	S	Direct
Common Stock	Disposition	2014-01-10	50	$92.85	97,974	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Buy Common Stock	Disposition	2014-01-10	22,500	$0.00	22,500	$18.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-06-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,080	Indirect	By Trust
Common Stock	260	Indirect	By LP
Common Stock	6,500	Indirect	By Wife

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option to Buy Common Stock	$17.63		2015-06-09	15,000	15,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-06-09	15,000	15,000	Direct

Footnotes

The exercise and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2013.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.53 to $92.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
Options are 100% vested.